These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans. Eisenhofer G; Brush JE; Cannon RO; Stull R; Kopin IJ; Goldstein DS J Clin Endocrinol Metab; 1989 Feb; 68(2):247-55. PubMed ID: 2563731 [TBL] [Abstract][Full Text] [Related]
9. Pattern of plasma levels of catecholamines in familial dysautonomia. Axelrod FB; Goldstein DS; Holmes C; Berlin D; Kopin IJ Clin Auton Res; 1996 Aug; 6(4):205-9. PubMed ID: 8902316 [TBL] [Abstract][Full Text] [Related]
10. Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Raskind MA; Peskind ER; Holmes C; Goldstein DS Biol Psychiatry; 1999 Sep; 46(6):756-65. PubMed ID: 10494443 [TBL] [Abstract][Full Text] [Related]
11. Alpha2-adrenoceptor-mediated restraint of norepinephrine synthesis, release, and turnover during immobilization in rats. Tjurmina OA; Goldstein DS; Palkovits M; Kopin IJ Brain Res; 1999 May; 826(2):243-52. PubMed ID: 10224302 [TBL] [Abstract][Full Text] [Related]
12. The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA and neuropeptide Y-like immunoreactivity in normal human subjects. Hetland ML; Eldrup E; Bratholm P; Christensen NJ Scand J Clin Lab Invest; 1991 May; 51(3):219-24. PubMed ID: 1909048 [TBL] [Abstract][Full Text] [Related]
13. Sources and significance of plasma levels of catechols and their metabolites in humans. Goldstein DS; Eisenhofer G; Kopin IJ J Pharmacol Exp Ther; 2003 Jun; 305(3):800-11. PubMed ID: 12649306 [TBL] [Abstract][Full Text] [Related]
14. Effects of a peripherally acting alpha 2-adrenoceptor antagonist (L-659,066) on hemodynamics and plasma levels of catechols in conscious rats. Szemeredi K; Stull R; Kopin IJ; Goldstein DS Eur J Pharmacol; 1989 Oct; 170(1-2):53-9. PubMed ID: 2575527 [TBL] [Abstract][Full Text] [Related]
15. Plasma levels of catechols during reflexive changes in sympathetic nerve activity. Garty M; Deka-Starosta A; Chang PC; Eisenhofer G; Zukowska-Grojec Z; Stull R; Kopin IJ; Goldstein DS Neurochem Res; 1989 Jun; 14(6):523-31. PubMed ID: 2503766 [TBL] [Abstract][Full Text] [Related]
16. Genotype and phenotype in familial dysautonomia. Axelrod FB; Goldstein DS; Holmes C; Kopin IJ Adv Pharmacol; 1998; 42():925-8. PubMed ID: 9328049 [No Abstract] [Full Text] [Related]
17. Value of the plasma norepinephrine/3,4-dihydroxyphenylglycol ratio for the diagnosis of pheochromocytoma. Lenders JW; Willemsen JJ; Beissel T; Kloppenborg PW; Thien T; Benraad TJ Am J Med; 1992 Feb; 92(2):147-52. PubMed ID: 1543198 [TBL] [Abstract][Full Text] [Related]
18. Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. Holmes C; Eisenhofer G; Goldstein DS J Chromatogr B Biomed Appl; 1994 Mar; 653(2):131-8. PubMed ID: 8205240 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Eisenhofer G; Goldstein DS; Stull R; Keiser HR; Sunderland T; Murphy DL; Kopin IJ Clin Chem; 1986 Nov; 32(11):2030-3. PubMed ID: 3096593 [TBL] [Abstract][Full Text] [Related]
20. Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Goldstein DS; Polinsky RJ; Garty M; Robertson D; Brown RT; Biaggioni I; Stull R; Kopin IJ Ann Neurol; 1989 Oct; 26(4):558-63. PubMed ID: 2510587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]